Overexpression and Hypomethylation of Flap Endonuclease 1 Gene in Breast and Other Cancers

Flap endonuclease 1 (FEN1) is a structure-specific nuclease best known for its critical roles in Okazaki fragment maturation, DNA repair, and apoptosis-induced DNA fragmentation. Functional deficiencies in FEN1, in the forms of somatic mutations and polymorphisms, have recently been shown to lead to autoimmunity, chronic inflammation, and predisposition to and progression of cancer. To explore how FEN1 contributes to cancer progression, we examined FEN1 expression using 241 matched pairs of cancer and corresponding normal tissues on a gene expression profiling array and validated differential expression by quantitative real-time PCR and immunohistochemistry. Furthermore, we defined the minimum promoter of human FEN1 and examined the methylation statuses of the 5′ region of the gene in paired breast cancer tissues. We show that FEN1 is significantly up-regulated in multiple cancers and the aberrant expression of FEN1 is associated with hypomethylation of the CpG island within the FEN1 promoter in tumor cells. The overexpression and promoter hypomethylation of FEN1 may serve as biomarkers for monitoring the progression of cancers. (Mol Cancer Res 2008;6(11):1710–7)

[1]  Illinois.,et al.  Cancer Genetics , 1976, British Journal of Cancer.

[2]  In-Sook Kim.  Down-regulation of human FEN-1 gene expression during differentiation of promyelocytic leukemia cells , 1998, Experimental & Molecular Medicine.

[3]  Luc Girard,et al.  Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer , 2003, Oncogene.

[4]  B. Shen,et al.  Concerted Action of Exonuclease and Gap-dependent Endonuclease Activities of FEN-1 Contributes to the Resolution of Triplet Repeat Sequences (CTG)n- and (GAA)n-derived Secondary Structures Formed during Maturation of Okazaki Fragments* , 2006, Journal of Biological Chemistry.

[5]  U. Lehmann,et al.  Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. , 2001, Methods.

[6]  V Shane Pankratz,et al.  Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.

[7]  Nam-Soon Kim,et al.  Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  T. Lindahl.  The action pattern of mammalian deoxyribonuclease IV. , 1971, European journal of biochemistry.

[9]  I Kimber,et al.  Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. , 2005, Journal of molecular endocrinology.

[10]  Jay Z. Parrish,et al.  CRN‐1, a Caenorhabditis elegans FEN‐1 homologue, cooperates with CPS‐6/EndoG to promote apoptotic DNA degradation , 2003, The EMBO journal.

[11]  R. Kucherlapati,et al.  Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  I. S. Kim,et al.  Gene expression of flap endonuclease-1 during cell proliferation and differentiation. , 2000, Biochimica et Biophysica Acta.

[13]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[14]  M. Szyf,et al.  Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis* , 2004, Journal of Biological Chemistry.

[15]  E. Latulippe,et al.  Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. , 2002, Cancer research.

[16]  M. Lieber,et al.  Functional domains within FEN-1 and RAD2 define a family of structure-specific endonucleases: implications for nucleotide excision repair. , 1994, Genes & development.

[17]  M. Szyf,et al.  Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications. , 2005, Current cancer drug targets.

[18]  A. Puisieux,et al.  Genome-wide analysis of gene expression in neuroblastomas detected by mass screening. , 2005, Cancer letters.

[19]  S. Baylin,et al.  Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. , 1991, Cancer cells.

[20]  M. Szyf,et al.  DNA demethylation and cancer: therapeutic implications. , 2004, Cancer letters.

[21]  T. Buterin,et al.  Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. , 2005, Carcinogenesis.

[22]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[23]  H. Magdelenat,et al.  DNA hypomethylation in breast cancer: an independent parameter of tumor progression? , 1997, Cancer genetics and cytogenetics.

[24]  M. Lieber.  The FEN‐1 family of structure‐specific nucleases in eukaryotic dna replication, recombination and repair , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  M. Christmann,et al.  Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibition , 2005, Oncogene.

[26]  P. Hall,et al.  Fen1 expression: a novel marker for cell proliferation , 1998, The Journal of pathology.

[27]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[28]  M. Lieber,et al.  The characterization of a mammalian DNA structure‐specific endonuclease. , 1994, The EMBO journal.

[29]  D. Lin,et al.  Fen1 mutations result in autoimmunity, chronic inflammation and cancers , 2007, Nature Medicine.

[30]  Jay Z. Parrish,et al.  Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks , 2005, EMBO reports.

[31]  S. Ikeda,et al.  Structure and transcription promoter activity of mouse flap endonuclease 1 gene: alternative splicing and bidirectional promoter. , 2005, Gene.

[32]  Christine A Iacobuzio-Donahue,et al.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.

[33]  S. Horvath,et al.  Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score , 2006, BJU international.

[34]  B. Van Houten,et al.  Up-regulation of base excision repair correlates with enhanced protection against a DNA damaging agent in mouse cell lines. , 1998, Nucleic acids research.

[35]  J. Turchi,et al.  Enzymatic completion of mammalian lagging-strand DNA replication. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  John R Yates,et al.  The deoxyribonucleic acid repair protein flap endonuclease-1 modulates estrogen-responsive gene expression. , 2007, Molecular endocrinology.

[37]  L. Finger,et al.  Multiple but dissectible functions of FEN‐1 nucleases in nucleic acid processing, genome stability and diseases , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[38]  E. Almqvist,et al.  The ‘flap’ endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion underlying Huntington disease , 2001, Clinical genetics.

[39]  B. Stillman,et al.  Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro , 1994, Nature.